Metyos, a health tech startup, has successfully raised €2.3 million ($2.5 million) in a pre-seed funding round to advance its mission of combating chronic kidney disease (CKD) through innovative technology. The company has developed a wearable device designed to monitor the condition, aiding in the early detection and management of CKD. The fundraising effort, highlighted by TechCrunch and supported by a compelling 8-slide pitch deck, attracted attention from investors including Kimaventures. Metyos, which is based in Paris, France, and led by a co-founder of Wandercraft, is a female-led initiative planning to utilize the funds for clinical trials. The startup's initiative has garnered attention for its focus on improving health outcomes for those suffering from CKD, marking a significant step forward in medtech.